Geoffrey L. Smith
Geoffrey Lilley Smith (born 1955) is a British virologist and medical research authority in the area of Vaccinia virus and the family of Poxviruses. Since 1 October 2011 he is head of the Department of Pathology at the University of Cambridge and a principal research fellow of the Wellcome Trust. Before that, he was head of the Department of Virology at Imperial College London. Provided by Wikipedia
Showing 1 - 13 results of 13 for search 'Geoffrey L. Smith', query time: 0.02s
Refine Results
-
1
-
2
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. by Ron A-J Chen, Grigory Ryzhakov, Samantha Cooray, Felix Randow, Geoffrey L Smith
Published 2008-02-01Get full text
Article -
3
Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence. by Pavla Strnadova, Hongwei Ren, Robert Valentine, Michela Mazzon, Trevor R Sweeney, Ian Brierley, Geoffrey L Smith
Published 2015-09-01Get full text
Article -
4
-
5
-
6
Selective modulation of cell surface proteins during vaccinia infection: A resource for identifying viral immune evasion strategies. by Delphine M Depierreux, Arwen F Altenburg, Lior Soday, Alice Fletcher-Etherington, Robin Antrobus, Brian J Ferguson, Michael P Weekes, Geoffrey L Smith
Published 2022-06-01Get full text
Article -
7
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. by Leonie Unterholzner, Rebecca P Sumner, Marcin Baran, Hongwei Ren, Daniel S Mansur, Nollaig M Bourke, Felix Randow, Geoffrey L Smith, Andrew G Bowie
Published 2011-09-01Get full text
Article -
8
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. by Nicholas E Peters, Nicholas E Peters, Brian J Ferguson, Michela Mazzon, Aodhnait S Fahy, Ewelina Krysztofinska, Raquel Arribas-Bosacoma, Laurence H Pearl, Hongwei Ren, Geoffrey L Smith
Published 2013-01-01Get full text
Article -
9
-
10
Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. by Carlos Maluquer de Motes, Samantha Cooray, Hongwei Ren, Gabriel M F Almeida, Kieran McGourty, Mohammad W Bahar, David I Stuart, Jonathan M Grimes, Stephen C Graham, Geoffrey L Smith
Published 2011-12-01Get full text
Article -
11
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. by Stephen C Graham, Mohammad W Bahar, Samantha Cooray, Ron A-J Chen, Daniel M Whalen, Nicola G A Abrescia, David Alderton, Raymond J Owens, David I Stuart, Geoffrey L Smith, Jonathan M Grimes
Published 2008-08-01Get full text
Article -
12
The nuclear localization signal of monkeypox virus protein P2 orthologue is critical for inhibition of IRF3-mediated innate immunity by Pengtao Jiao, Jianing Ma, Yuna Zhao, Xiaoxiao Jia, Haoran Zhang, Wenhui Fan, Xiaojuan Jia, Xiaoyuan Bai, Yiqi Zhao, Yongxu Lu, He Zhang, Jiayin Guo, Gang Pang, Ke Zhang, Min Fang, Minghua Li, Wenjun Liu, Geoffrey L. Smith, Lei Sun
Published 2024-12-01Get full text
Article -
13
T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination by Ji-Li Chen, Beibei Wang, Yongxu Lu, Elie Antoun, Olivia Bird, Philip G. Drennan, Zixi Yin, Guihai Liu, Xuan Yao, Maya Pidoux, Adam Bates, Deshni Jayathilaka, Junyuan Wang, Brian Angus, Sally Beer, Alexis Espinosa, J. Kenneth Baillie, Malcolm G. Semple, ISARIC4C Investigators, Timothy Rostron, Craig Waugh, Paul Sopp, Julian C. Knight, James N. Fullerton, Mark Coles, Geoffrey L. Smith, Alexander J. Mentzer, Yanchun Peng, Tao Dong
Published 2025-05-01Get full text
Article